Kane Biotech (TSE:KNE) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Kane Biotech has gained attention with a new publication in Pathogens journal and multiple conference presentations, highlighting the potential of their enzyme DispersinB® as a broad-spectrum antibiofilm agent. The company’s ongoing research efforts are showcased through presentations on the antibiofilm properties of revyve™ Antimicrobial Wound Gel Spray, signalling a commitment to advancing biofilm science and developing effective treatments for chronic wound infections.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
